Change of Adviser
18 Julho 2007 - 9:30AM
UK Regulatory
RNS Number:4555A
GeneMedix PLC
18 July 2007
GeneMedix plc
(AIM: GMX)
Appointment of Deloitte Corporate Finance as new NOMAD
GeneMedix plc ("the Company"), the AIM listed biopharmaceutical company,
announces the appointment of Deloitte Corporate Finance to act as Nominated
Adviser to the Company with immediate effect.
18 July 2007
ENQUIRIES:
GeneMedix plc Tel: 01638 663 320
Julian Attfield, Chief Executive Officer
Deloitte Corporate Finance Tel: 020 7936 3000
Jonathan Hinton / John Ball
Bankside Consultants Tel: 020 7367 8888
Michael Padley / Susan Scott
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPRPMTTMMBBBJR
Reliance Genemedix (LSE:GMX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Reliance Genemedix (LSE:GMX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Reliance Gen. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Genemedix Plc